(Q51186546)

1 April 2018

title

The emergence of non-albicans Candida species as causes of invasive candidiasis and candidemia. (English)

1 reference

1 April 2018

1 reference

1 reference

1 reference

1 reference

1

Jack D Sobel

1 reference

1 April 2018

language of work or name

1 reference

1 November 2006

1 reference

1 April 2018

number of pages

7

1 reference

Current infectious disease reports

inferred from page(s)

published in

1 reference

1 April 2018

volume

8

1 reference

1 April 2018

page(s)

427-433

1 reference

1 April 2018

issue

6

1 reference

1 April 2018

Epidemiology of nosocomial fungal infections, with emphasis on Candida species

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0016-6

Importance of Candida species other than C. albicans as pathogens in oncology patients

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11908-006-0016-6

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

21 January 2018

1 reference

12 December 2020

The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance

1 reference

12 December 2020

Epidemiologic and molecular characterization of an outbreak of Candida parapsilosis bloodstream infections in a community hospital

1 reference

12 December 2020

Incidence of bloodstream infections due to Candida species and in vitro susceptibilities of isolates collected from 1998 to 2000 in a population-based active surveillance program

1 reference

12 December 2020

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

1 reference

12 December 2020

The epidemiology of hematogenous candidiasis caused by different Candida species

1 reference

12 December 2020

In vitro activities of voriconazole in combination with three other antifungal agents against Candida glabrata

1 reference

12 December 2020

Characteristics of candidaemia with Candida-albicans compared with non-albicans Candida species and predictors of mortality

1 reference

12 December 2020

Candida glabrata fungemia: experience in a tertiary care center

1 reference

12 December 2020

International surveillance of bloodstream infections due to Candida species: frequency of occurrence and antifungal susceptibilities of isolates collected in 1997 in the United States, Canada, and South America for the SENTRY Program. The SENTRY Par

1 reference

12 December 2020

Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

1 reference

12 December 2020

The epidemiology of Candida glabrata and Candida albicans fungemia in immunocompromised patients with cancer

1 reference

12 December 2020

In vitro susceptibilities of Candida bloodstream isolates to the new triazole antifungal agents BMS-207147, Sch 56592, and voriconazole

1 reference

12 December 2020

Invasive candida infections--evolution of a fungal pathogen

1 reference

12 December 2020

Amphotericin B and caspofungin resistance in Candida glabrata isolates recovered from a critically ill patient

1 reference

12 December 2020

Triazole cross-resistance among Candida spp.: case report, occurrence among bloodstream isolates, and implications for antifungal therapy

1 reference

12 December 2020

Secular trends of candidemia in a large tertiary-care hospital from 1988 to 2000: emergence of Candida parapsilosis

1 reference

12 December 2020

Attributable mortality of nosocomial candidemia, revisited

1 reference

12 December 2020

The contribution of fluconazole to the changing epidemiology of invasive candidal infections

1 reference

12 December 2020

Biofilm production by isolates of Candida species recovered from nonneutropenic patients: comparison of bloodstream isolates with isolates from other sources

1 reference

12 December 2020

Geographic variation in the susceptibilities of invasive isolates of Candida glabrata to seven systemically active antifungal agents: a global assessment from the ARTEMIS Antifungal Surveillance Program conducted in 2001 and 2002.

1 reference

12 December 2020

Epidemiology of Candida species infections in critically ill non-immunosuppressed patients

1 reference

12 December 2020

Rapid acquisition of stable azole resistance by Candida glabrata isolates obtained before the clinical introduction of fluconazole

1 reference

12 December 2020

Guidelines for treatment of candidiasis

1 reference

12 December 2020

The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.

1 reference

12 December 2020

Global trends in candidemia: review of reports from 1995-2005.

1 reference

12 December 2020

Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy

1 reference

12 December 2020

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

12 December 2020

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

12 December 2020

Treatment of Candida glabrata infection in immunosuppressed mice by using a combination of liposomal amphotericin B with caspofungin or micafungin

1 reference

12 December 2020

Breakthrough fungal infections in stem cell transplant recipients receiving voriconazole.

1 reference

12 December 2020

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

1 reference

12 December 2020

Epidemiology of candidaemia and antifungal susceptibility patterns in an Italian tertiary-care hospital

1 reference

12 December 2020

Comparison of caspofungin and amphotericin B for invasive candidiasis

1 reference

12 December 2020

Evolution of vaginal Candida species recovered from human immunodeficiency virus-infected women receiving fluconazole prophylaxis: the emergence of Candida glabrata? Terry Beirn Community Programs for Clinical Research in AIDS (CPCRA).

1 reference

12 December 2020

Prior antimicrobial therapy and risk for hospital-acquired Candida glabrata and Candida krusei fungemia: a case-case-control study

1 reference

12 December 2020

Neonatal candidiasis: analysis of epidemiology, drug susceptibility, and molecular typing of causative isolates

1 reference

12 December 2020

Twelve years of fluconazole in clinical practice: global trends in species distribution and fluconazole susceptibility of bloodstream isolates of Candida.

1 reference

12 December 2020

Clinical significance of azole antifungal drug cross-resistance in Candida glabrata

1 reference

12 December 2020

Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.

1 reference

12 December 2020

Caspofungin activity against clinical isolates of fluconazole-resistant Candida

1 reference

12 December 2020

Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America. SENTRY Participants Group

1 reference

12 December 2020

National surveillance of nosocomial blood stream infection due to species of Candida other than Candida albicans: frequency of occurrence and antifungal susceptibility in the SCOPE Program. SCOPE Participant Group. Surveillance and Control of Pathog

1 reference

12 December 2020

10.1007/S11908-006-0016-6

Identifiers

DOI

1 reference

1 April 2018

PubMed ID

17064635

1 reference

1 April 2018